We have previously reported that ONA inhibits tumor progression in sarcoma and ovarian cancers by regulating macrophage activation [36, 40]; however, this is the first evidence that ONA can inhibit STAT 3 activation induced by IL-6, which was derived from macrophages in SCLC cells. Here, IL6 is linked to ovarian cancer.